Related references
Note: Only part of the references are listed.Intramuscular Injection of AAV8 in Mice and Macaques Is Associated with Substantial Hepatic Targeting and Transgene Expression
Jenny A. Greig et al.
PLOS ONE (2014)
Direct Expression and Validation of Phage-selected Peptide Variants in Mammalian Cells
Brian D. Quinlan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Enhanced Recognition and Neutralization of HIV-1 by Antibody-Derived CCR5-Mimetic Peptide Variants
Jessica J. Chiang et al.
JOURNAL OF VIROLOGY (2012)
A Novel Assay for Antibody-Dependent Cell-Mediated Cytotoxicity against HIV-1-or SIV-Infected Cells Reveals Incomplete Overlap with Antibodies Measured by Neutralization and Binding Assays
Michael D. Alpert et al.
JOURNAL OF VIROLOGY (2012)
A Species-Specific Amino Acid Difference in the Macaque CD4 Receptor Restricts Replication by Global Circulating HIV-1 Variants Representing Viruses from Recent Infection
Daryl Humes et al.
JOURNAL OF VIROLOGY (2012)
Antibody-based protection against HIV infection by vectored immunoprophylaxis
Alejandro B. Balazs et al.
NATURE (2012)
Broad and potent neutralization of HIV-1 by a gp41-specific human antibody
Jinghe Huang et al.
NATURE (2012)
ADCC Develops Over Time during Persistent Infection with Live-Attenuated SIV and Is Associated with Complete Protection against SIVmac251 Challenge
Michael D. Alpert et al.
PLOS PATHOGENS (2012)
Structural Mechanism of Trimeric HIV-1 Envelope Glycoprotein Activation
Erin E. H. Tran et al.
PLOS PATHOGENS (2012)
A Tyrosine-Sulfated CCR5-Mimetic Peptide Promotes Conformational Transitions in the HIV-1 Envelope Glycoprotein
Jo Ann Kwong et al.
JOURNAL OF VIROLOGY (2011)
Broad neutralization coverage of HIV by multiple highly potent antibodies
Laura M. Walker et al.
NATURE (2011)
Increasing the Potency and Breadth of an HIV Antibody by Using Structure-Based Rational Design
Ron Diskin et al.
SCIENCE (2011)
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding
Johannes F. Scheid et al.
SCIENCE (2011)
Tiered Categorization of a Diverse Panel of HIV-1 Env Pseudoviruses for Assessment of Neutralizing Antibodies
Michael S. Seaman et al.
JOURNAL OF VIROLOGY (2010)
Human hematopoietic stem/progenitor cells modified by zinc-finger nucleases targeted to CCR5 control HIV-1 in vivo
Nathalia Holt et al.
NATURE BIOTECHNOLOGY (2010)
sCD4-17b bifunctional protein: Extremely broad and potent neutralization of HIV-1 Env pseudotyped viruses from genetically diverse primary isolates
Laurel A. Lagenaur et al.
RETROVIROLOGY (2010)
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1
Xueling Wu et al.
SCIENCE (2010)
Evidence that Ecotropic Murine Leukemia Virus Contamination in TZM-bl Cells Does Not Affect the Outcome of Neutralizing Antibody Assays with Human Immunodeficiency Virus Type 1
Emily J. Platt et al.
JOURNAL OF VIROLOGY (2009)
Vector-mediated gene transfer engenders long-lived neutralizing activity and protection against SIV infection in monkeys
Philip R. Johnson et al.
NATURE MEDICINE (2009)
Soluble CD4 and CD4-Mimetic Compounds Inhibit HIV-1 Infection by Induction of a Short-Lived Activated State
Hillel Haim et al.
PLOS PATHOGENS (2009)
Identification of Gammaretroviruses Constitutively Released from Cell Lines Used for Human Immunodeficiency Virus Research
Yasuhiro Takeuchi et al.
JOURNAL OF VIROLOGY (2008)
Structures of the CCR5 N terminus and of a tyrosine-sulfated antibody with HIV-1 gp120 and CD4
Chih-chin Huang et al.
SCIENCE (2007)
Nonlinear pharmacokinetics of high-dose recombinant fusion protein CD4-IgG(2) (PRO 542) observed in HIV-1-infected children
Courtney V. Fletcher et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2007)
A tyrosine-sulfated peptide derived from the heavy-chain CDR3 region of an HIV-1-neutralizing antibody binds gp120 and inhibits HIV-1 infection
Tatyana Dorfman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Human immunodeficiency virus type 1 env clones from acute and early subtype B infections for standardized assessments of vaccine-elicited neutralizing antibodies
M Li et al.
JOURNAL OF VIROLOGY (2005)
A human T-cell leukemia virus type 1 regulatory element enhances the immunogenicity of human immunodeficiency virus type 1 DNA vaccines in mice and nonhuman primates
DH Barouch et al.
JOURNAL OF VIROLOGY (2005)
Transfer and evaluation of an automated, low-cost real-time reverse transcription-PCR test for diagnosis and monitoring of human immunodeficiency virus type 1 infection in a west African resource-limited setting
F Rouet et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Structural basis of tyrosine sulfation and VH-gene usage in antibodies that recognize the HIV type 1 coreceptor-binding site on gp120
CC Huang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Tyrosine sulfation of human antibodies contributes to recognition of the CCR5 binding region of HIV-1 gp120
H Choe et al.
CELL (2003)
Generation of neutralizing activity against human immunodeficiency virus type 1 in serum by antibody gene transfer
AD Lewis et al.
JOURNAL OF VIROLOGY (2002)
Emergence of resistant human immunodeficiency virus type 1 in patients receiving fusion inhibitor (T-20) monotherapy
XP Wei et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2002)
Mucosal transmission and induction of simian AIDS by CCR5-specific simian/human immunodeficiency virus SHIVSF162P3
JM Harouse et al.
JOURNAL OF VIROLOGY (2001)
A tyrosine-sulfated peptide based on the N terminus of CCR5 interacts with a CD4-enhanced epitope of the HIV-1 gp120 envelope glycoprotein and inhibits HIV-1 entry
M Farzan et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2000)
Sensitivity of human immunodeficiency virus type 1 to the fusion inhibitor T-20 is modulated by coreceptor specificity defined by the V3 loop of gp120
CA Derdeyn et al.
JOURNAL OF VIROLOGY (2000)
Single-dose safety, pharmacology, and antiviral activity of the human immunodeficiency virus (HIV) type 1 entry inhibitor PRO 542 in HIV-infected adults
JM Jacobson et al.
JOURNAL OF INFECTIOUS DISEASES (2000)